Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Angiodynamics (ANGO) Non-Current Deferred Tax Liability (2016 - 2025)

Angiodynamics (ANGO) has disclosed Non-Current Deferred Tax Liability for 13 consecutive years, with $4.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Non-Current Deferred Tax Liability changed 0.07% year-over-year to $4.3 million, compared with a TTM value of $4.3 million through Nov 2025, changed 0.07%, and an annual FY2025 reading of $4.1 million, down 16.06% over the prior year.
  • Non-Current Deferred Tax Liability was $4.3 million for Q4 2025 at Angiodynamics, up from $4.3 million in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $22.4 million in Q1 2021 and bottomed at $1.3 million in Q3 2023.
  • Average Non-Current Deferred Tax Liability over 5 years is $11.2 million, with a median of $13.2 million recorded in 2023.
  • The sharpest move saw Non-Current Deferred Tax Liability crashed 91.54% in 2023, then soared 261.69% in 2024.
  • Year by year, Non-Current Deferred Tax Liability stood at $18.0 million in 2021, then decreased by 20.58% to $14.3 million in 2022, then increased by 24.27% to $17.8 million in 2023, then crashed by 75.59% to $4.3 million in 2024, then fell by 0.07% to $4.3 million in 2025.
  • Business Quant data shows Non-Current Deferred Tax Liability for ANGO at $4.3 million in Q4 2025, $4.3 million in Q3 2025, and $4.1 million in Q2 2025.